Greenbrook: Funding, Investors & Team (Sep 2026)
Greenbrook TMS owns and operates healthcare centers providing repetitive transcranial magnetic stimulation therapy (TMS) for the treatment of major depressive disorder (MDD) and other neurological diseases. Local electromagnetic stimulation is given during TMS therapy to certain brain areas known to be directly involved in mood regulation. Spravato is promoted to treat depressive symptoms in adults with MDD who have suicidal thoughts or behaviors as well as adults with treatment-resistant depression. In order to give patients a thorough treatment experience, Greenbrook handles insurance coverage and handles logistics while keeping the clients informed and involved in the procedure.
Greenbrook has raised $13.9M across 5 funding rounds on record, the most recent an undisclosed round of $1.2M announced in Feb 2024.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Greenbrook Company Profile and Key Stats
Latest funding round on record: Feb 2024.
Greenbrook Funding Rounds
Greenbrook raised $2.8M in an undisclosed round announced in Feb 2023.
5 months later, an undisclosed round of $4.4M was announced in Jul 2023.
3 months later, an undisclosed round of $1.5M was announced in Oct 2023.
2 months later, an undisclosed round of $4.0M was announced in Dec 2023.
2 months later, an undisclosed round of $1.2M was announced in Feb 2024.
Greenbrook Founders and Leadership Team
Contact details for the Greenbrook team: 1 of 2 have an email address on file.
Start 14-day free trial →Greenbrook Funding Compared to Other Biotechnology Startups
Greenbrook's latest round of $1.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Greenbrook in Biotechnology and Mclean
Companies Similar to Greenbrook
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Greenbrook Funding FAQs
What does Greenbrook do?
Greenbrook TMS owns and operates healthcare centers providing repetitive transcranial magnetic stimulation therapy (TMS) for the treatment of major depressive disorder (MDD) and other neurological diseases. Local electromagnetic stimulation is given during TMS therapy to certain brain areas known to be directly involved in mood regulation. Spravato is promoted to treat depressive symptoms in adults with MDD who have suicidal thoughts or behaviors as well as adults with treatment-resistant depression. In order to give patients a thorough treatment experience, Greenbrook handles insurance coverage and handles logistics while keeping the clients informed and involved in the procedure.
How much funding has Greenbrook raised?
Greenbrook has raised $13.9M across 5 rounds on record. The most recent is an undisclosed round of $1.2M announced in Feb 2024.
When did Greenbrook last raise funding?
Greenbrook's most recent funding round on record is an undisclosed round of $1.2M, announced in Feb 2024.
Who is the CEO of Greenbrook?
Bill Leonard is listed as CEO at Greenbrook.
Where is Greenbrook headquartered?
Greenbrook is based in Mclean, Virginia, United States.
How many employees does Greenbrook have?
Greenbrook is in the 251-500 employee band.
How does Greenbrook's funding compare to other Biotechnology startups?
Greenbrook's latest round of $1.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Greenbrook Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Greenbrook is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.